Sample results
Transplant rejection occurs when the recipient's immune system recognizes the transplanted organ or tissue as foreign and attacks it. It is caused by mismatched human leukocyte antigens (HLA) between the donor and recipient, triggering an immune response against the transplanted cells. The HLA A,B,C Low Resolution test is the most important test for assessing transplant compatibility and rejection risk.
Transplant rejection is caused by mismatched human leukocyte antigens (HLA) between the donor and recipient, which triggers the immune system to recognize the transplanted organ or tissue as foreign. Your immune system uses HLA proteins as markers to identify which cells belong to your body and which do not. When HLA antigens from the donor differ significantly from yours, your immune cells attack the transplanted tissue as if it were a dangerous invader, leading to acute or chronic rejection that can damage or destroy the transplant.
The HLA A,B,C Low Resolution test is the most important test for transplant rejection because it analyzes the human leukocyte antigens that determine compatibility between donor and recipient. This test identifies specific HLA proteins on cell surfaces that, when mismatched, significantly increase rejection risk. Before transplantation, this test helps match donors and recipients to minimize rejection chances. For bone marrow transplant recipients, the FISH, X/Y, Post Opposite Sex Bone Marrow Transplant test is essential for monitoring transplant success by measuring the ratio of donor cells to recipient cells, with higher recipient cell percentages indicating possible rejection.
You should get tested if you are being evaluated as a transplant candidate or potential organ donor to assess compatibility. HLA typing is performed before any organ or tissue transplant to match donors and recipients. After receiving a bone marrow transplant from an opposite-sex donor, you should get periodic FISH testing to monitor transplant engraftment and detect early signs of rejection. Additionally, your transplant team may order testing if you experience symptoms like fever, pain at the transplant site, decreased organ function, or other signs that might indicate rejection.
What this means
Your HLA-B27 test came back negative, meaning you do not carry this particular genetic marker associated with certain autoimmune conditions like ankylosing spondylitis. This is the most common result and significantly lowers your genetic risk for B27-associated inflammatory diseases.
Recommended actions
Maintain an anti-inflammatory diet with omega-3 rich foods and colorful vegetables
Continue regular exercise and maintain good posture to support spine and joint health
Stay aware of family history and report any new joint pain or stiffness to your doctor
If experiencing symptoms, discuss comprehensive autoimmune screening with your healthcare provider
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: